Drug profile · INN
concizumab
ALHEMO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
concizumab (ALHEMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN concizumab
Brand ALHEMO
Route INJECTION
Formulation SOLUTION
ATC code B02BX10
Frequently asked questions
What is concizumab?
concizumab (ALHEMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for concizumab?
ALHEMO is a marketed brand name for concizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of concizumab?
concizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.